These data are further supported by the work of Stovgaard et al., who examined LAG-3 expression using immunohistochemistry on 514 TNBC tumor sections, demonstrating that a higher LAG-3 expression at the protein level was associated with longer OS and RFS [31]. The gene discussed is LAG3; the disease is neoplasm.